0001623526-18-000002.txt : 20181102 0001623526-18-000002.hdr.sgml : 20181102 20181102122152 ACCESSION NUMBER: 0001623526-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181102 DATE AS OF CHANGE: 20181102 EFFECTIVENESS DATE: 20181102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stoke Therapeutics, Inc. CENTRAL INDEX KEY: 0001623526 IRS NUMBER: 471144582 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-324958 FILM NUMBER: 181156177 BUSINESS ADDRESS: STREET 1: 3 PRESTON COURT CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 781-430-8200 MAIL ADDRESS: STREET 1: 3 PRESTON COURT CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ASOthera Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20141028 D 1 primary_doc.xml X0708 D LIVE 0001623526 Stoke Therapeutics, Inc. 3 Preston Court Bedford MA MASSACHUSETTS 01730 (781) 430-8200 DELAWARE ASOthera Pharmaceuticals, Inc. Corporation true 2014 Edward M. Kaye c/o Stoke Therapeutics, Inc. 3 Preston Court Bedford MA MASSACHUSETTS 01730 Executive Officer Director Huw M. Nash c/o Stoke Therapeutics, Inc. 3 Preston Court Bedford MA MASSACHUSETTS 01730 Executive Officer Barry Ticho c/o Stoke Therapeutics, Inc. 3 Preston Court Bedford MA MASSACHUSETTS 01730 Executive Officer Gene Liau c/o Stoke Therapeutics, Inc. 3 Preston Court Bedford MA MASSACHUSETTS 01730 Executive Officer Isabel Aznarez c/o Stoke Therapeutics, Inc. 3 Preston Court Bedford MA MASSACHUSETTS 01730 Executive Officer Promoter Charles R. Allerson c/o Stoke Therapeutics, Inc. 3 Preston Court Bedford MA MASSACHUSETTS 01730 Executive Officer Meena Meena c/o Stoke Therapeutics, Inc. 3 Preston Court Bedford MA MASSACHUSETTS 01730 Executive Officer Adrian Krainer c/o Stoke Therapeutics, Inc. 3 Preston Court Bedford MA MASSACHUSETTS 01730 Executive Officer Director Promoter Arthur A. Levin c/o Stoke Therapeutics, Inc. 3 Preston Court Bedford MA MASSACHUSETTS 01730 Director Seth L. Harrison c/o Stoke Therapeutics, Inc. 3 Preston Court Bedford MA MASSACHUSETTS 01730 Director Samuel W. Hall c/o Stoke Therapeutics, Inc. 3 Preston Court Bedford MA MASSACHUSETTS 01730 Director Arthur Tzianabos c/o Stoke Therapeutics, Inc. 3 Preston Court Bedford MA MASSACHUSETTS 01730 Director Biotechnology Decline to Disclose 06b false 2018-10-22 false true false 0 90000000 90000000 0 false 14 0 0 0 false Stoke Therapeutics, Inc. /s/ Edward M. Kaye, M.D. Edward M. Kaye, M.D. Chief Executive Officer 2018-11-01